Table 1.
Subject demographics and clinical summary
| Sample characteristics | Statistics | ||
|---|---|---|---|
| mTBI (n = 100) | Controls (n = 20) | Statistics (P‐value) | |
| Demographic | |||
| Age | 14.06 (2.4) | 14.44 (3.0) | — |
| Gender | |||
| Male/female | 45/55 | 9/11 | — |
| Symptoms | |||
| Headache | 3.20 (1.5) | 1.40 (0.8) | 8 × 10−4 |
| Dizziness | 1.72 (1.1) | 1.20 (0.5) | 0.038 |
| Irritability | 2.20 (1.3) | 1.40 (0.8) | 0.031 |
| Fatigue | 2.40 (1.2) | 0.50 (0.7) | 2 × 10−6 |
| Sleep | 1.82 (0.9) | 1.40 (0.7) | 9 × 10−7 |
| Total PCSI score | 18.0 (0–75) | 3.90 (0–21) | 4.5 × 10−5 |
| Behavioral measures | |||
| CNS VS | |||
| Neurocognition index | 98.40 (11.7) | 101.50 (10.8) | — |
| Executive function | 102.31 (13.4) | 105.80 (12.2) | — |
| BASC‐2 | |||
| Behavioral Symptoms Index | 48.70 (7.5) | 45.05 (8.8) | — |
| Anxiety | 51.90 (12.2) | 45.94 (6.6) | — |
| BRIEF | |||
| Working Memory | 53.30 (10.1) | 49.10 (8.7) | — |
| Behavioral Regulation Index | 49.23 (9.2) | 45.85 (8.0) | — |
Participant demographics including sample size, age profile for the two groups and gender distribution; with mean and standard deviation (SD) where appropriate. Regarding symptoms, the median symptom scale and PCSI (Likert‐scale) for the whole cohort are shown. CNS VS: Computerized Neurocognitive Software Vital Signs, Standard score; BASC‐2: Behavior Assessment System for Children, second edition (T scores); BRIEF: Behavior Rating Inventory Executive Function (T Scores). The Chi Square test was used to assess putative group difference in Age whereas the Wilcoxon rank sum test was used to assess differences in symptoms and behavioral measures. “—” indicates non‐significant values.